Greater progression of coronary artery calcification is associated with clinically relevant cognitive impairment in type 1 diabetes
Jingchuan Guo(University of Pittsburgh), Trevor J. Orchard(University of Pittsburgh), Daniel Edmundowicz(Temple University Hospital), Tina Costacou(University of Pittsburgh), Karen A. Nunley(University of Pittsburgh), Caterina Rosano(University of Pittsburgh), Rachel G. Miller(University of Pittsburgh)
Cited by 12
Related Papers
Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study
|The Journal of Clinical Endocrinology & Metabolism|2016|518
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials
|The Lancet|2008|450
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial
|The Lancet|2008|432
Evidence for an Association between Metabolic Cardiovascular Syndrome and Coronary and Aortic Calcification among Women with Polycystic Ovary Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2004|274
Treatment of Patients Admitted to the Hospital With Congestive Heart Failure: Specialty-Related Disparities in Practice Patterns and Outcomes
|Journal of the American College of Cardiology|1997|251